REGENXBIO, Inc. is a company in the U.S. stock market and it is a holding in 80 U.S.-traded ETFs. RGNX has around 8.1M shares in the U.S. ETF market. The largest ETF holder of RGNX is the iShares Core S&P Small-Cap ETF (IJR), with approximately 2.31M shares. Investors may also find of interest that the ETF with the largest allocation to RGNX stock is Invesco Dynamic Biotechnology & Genome ETF (PBE), with a portfolio weight of 2.51%. On average, U.S. ETFs allocate 0.18% of RGNX to their portfolios.
Additionally, RGNX is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with RGNX as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%.